
Elranatamab: Bispecific mAb Bioassay Strategy from R&D to Commercialization

Speaker Presentation: Bioassays 2025
Richard Peter, Pfizer, Inc., 2025
Elranatamab: Bispecific mAb Bioassay Strategy from R&D to Commercialization
Speaker Presentation: Bioassays 2025
Richard Peter, Pfizer, Inc., 2025
Elranatamab: Bispecific mAb Bioassay Strategy from R&D to Commercialization